🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Safety, tolerability and efficacy of BI 655066 in male and female patients ...
Status
Completed
Location
1311.1.0007 Boehringer Ingelheim Investigational Site
Start Date
2012-04
Trial ID
NCT01577550
The purpose of this study is to evaluate the safety and efficacy of risanki...
Status
Completed
Location
Pinnacle Research Group /ID# 167953
Start Date
2019-03-07
Trial ID
NCT03671148
Treatments Being Tested
The main objective of this study is to evaluate the efficacy and safety of ...
Status
Completed
Location
Advanced Research Associates - Glendale /ID# 204335
Start Date
2018-05-08
Trial ID
NCT03478787
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of risankizu...
Status
Completed
Location
GBUZ Clinical Dermatovenerology Dispensary of MoH of Krasnodar region /ID# 201713
Start Date
2018-07-19
Trial ID
NCT03518047
Treatments Being Tested
Safety, tolerability and pharmacokinetics of single dose of BI 655066/ABBV-...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2015-08
Trial ID
NCT02596217
To assess the influence of risankizumab on kinetics of cytochrome P450 (CYP...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2016-09-15
Trial ID
NCT02772601
Treatments Being Tested
This is a randomized double blind, double dummy, placebo controlled, parall...
Status
Completed
Location
Multiple Locations
Start Date
2016-12-02
Trial ID
NCT03000075
Treatments Being Tested
This is a randomized double blind, double dummy, placebo and active compara...
Status
Completed
Location
Multiple Locations
Start Date
2016-03
Trial ID
NCT02684357
Treatments Being Tested
The primary objective of the study was to investigate long-term safety of r...
Status
Completed
Location
MGG Group, Inc.Chevy Chase Clinical Research /ID# 155068
Start Date
2015-09-16
Trial ID
NCT02513459
Treatments Being Tested
This study is a proof of concept, multi-center, randomized, double-blind, p...
Status
Completed
Location
Multiple Locations
Start Date
2014-02
Trial ID
NCT02031276
Treatments Being Tested